LAWRENCE, Mass., Feb. 1 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will participate in the Merrill Lynch Pharmaceutical, Biotechnology & Medical Device Conference. Mr. Burbank is scheduled to present an overview of the Company at 8:40 a.m. Eastern Time on Thursday, February 7, 2008 at The Grand Hyatt at Park Avenue in New York.
To listen to the audio web cast of the presentation during the event, please visit: http://www.nxstage.com and click on 'Investor Information.' A replay will be available for 14 days immediately following the live presentation.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at http://www.nxstage.com.
This release contains "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995. All statements
contained in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended to
identify forward-looking statements. The forward-looking statements in this
release include NxStage's plan to present at the Merrill Lynch Global
Pharmaceutical & Medical Device Conference. Actual results may differ
materially from those indicated by these forward-looking statements as a
result of various important factors including, but not limited to,
unexpected difficulty in getting to the conference and other factors that
are discussed in NxStage's filings with the Securities and Exchange
Commission, including the Quarterly Report on Form 10-Q for the quarter
ended September 30, 2007. NxStage is under no obligation to (and expressly
disclaims any such obligation to) update or alter its forward- looking
statements, whether as a result of new information, future events or
Investor Relations Contact
Stephanie Marks for NxStage
|SOURCE NxStage Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved